Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharma-Bio Serv (PBSV) EPS (Basic) (2016 - 2026)

Pharma-Bio Serv's EPS (Basic) history spans 17 years, with the latest figure at $0.0 for Q1 2026.

  • For Q1 2026, EPS (Basic) rose 285.84% year-over-year to $0.0; the TTM value through Jan 2026 reached -$0.0, up 82.78%, while the annual FY2025 figure was -$0.0, 87.07% up from the prior year.
  • EPS (Basic) reached $0.0 in Q1 2026 per PBSV's latest filing, up from -$0.0 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.02 in Q3 2023 to a low of -$0.01 in Q3 2024.
  • Average EPS (Basic) over 5 years is $0.0, with a median of $0.0 recorded in 2026.
  • Peak YoY movement for EPS (Basic): crashed 163.44% in 2024, then surged 285.84% in 2026.
  • A 5-year view of EPS (Basic) shows it stood at $0.01 in 2022, then tumbled by 127.23% to -$0.0 in 2023, then skyrocketed by 134.18% to $0.0 in 2024, then plummeted by 100.63% to -$0.0 in 2025, then skyrocketed by 32374.05% to $0.0 in 2026.
  • Per Business Quant, the three most recent readings for PBSV's EPS (Basic) are $0.0 (Q1 2026), -$0.0 (Q4 2025), and -$0.01 (Q3 2025).